Traws Pharma (TRAW) Preferred Dividend Payments (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Preferred Dividend Payments of -$1.4 million for Q1 2026, down 122.09% year-over-year from $6.4 million in Q1 2025, and up 30.81% quarter-over-quarter from -$2.0 million in Q4 2025.
Traws Pharma (TRAW) Preferred Dividend Payments (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Preferred Dividend Payments for 5 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Dividend Payments fell 122.09% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$4.7 million (up 95.81% YoY), while the FY2025 annual figure was $2.3 million, up 102.06% from the prior year.
- Preferred Dividend Payments climbed to -$1.4 million in Q1 2026 per TRAW's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $6.4 million in Q1 2025 and bottomed at -$102.4 million in Q2 2024.
- Historically, Preferred Dividend Payments has averaged -$14.5 million across 3 years, with a median of -$1.7 million in 2025.
- Annual changes were most pronounced in 2025 — Preferred Dividend Payments surged 99.72% — and 2026, when it sank 122.09%.
- Traws Pharma's Preferred Dividend Payments stood at -$8.5 million in 2024, then jumped by 75.95% to -$2.0 million in 2025, then soared by 30.81% to -$1.4 million in 2026.
- Business Quant data shows TRAW's Preferred Dividend Payments at -$1.4 million in Q1 2026, -$2.0 million in Q4 2025, and -$927000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | -443,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -927,000.00 |
| Jun 30, 2025 | -290,000.00 |
| Mar 31, 2025 | 6.41 Mn |
| Dec 31, 2024 | -8.50 Mn |
| Sep 30, 2024 | -7.04 Mn |
| Jun 30, 2024 | -102.37 Mn |
| Sep 30, 2013 | 269,000.00 |
| Jun 30, 2013 | 1.03 Mn |
| Mar 31, 2013 | 1.02 Mn |
| Dec 31, 2012 | 1.01 Mn |
| Sep 30, 2012 | 785,000.00 |
| Jun 30, 2012 | 927,000.00 |
| Mar 31, 2012 | 1.23 Mn |